Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Angel Biotechmology Holdings (ABH) has acquired the biomaterial and collagen manufacturing business in Glasgow, UK, for a total cash consideration of £200,000.
Subscribe to our email newsletter
ABH’s wholly owned subsidiary, Angel Biomedical Ltd (ABL) will take ownership of the manufacturing plant.
The 6,500ft² facility comprises one large Grade C clean room, two smaller grade B rooms, and laboratory and office suite, for the production of purified GMP medical grade collagen.
ABH executive chairman Paul Harper said the formation of ABL provides significant strategic advantages to the Group, and the distinctive competencies offered will provide a one-stop shop for companies in the regenerative medicine space.
"ABL will also provide access to a range of new markets by offering customers the means by which to convert advanced biologics and cell therapies currently being manufactured by Angel into formulated, finished products such as medical devices and in vitro diagnostics," Harper added.